Feature Channels: Neuro

• share
• favorite_border

Children and adolescents who speak more than one language may reach adulthood with more grey matter, according to a new study.

• share
• favorite_border

If you have moderate-to-high risk of kidney failure as a young adult, you may be at risk for worse cognitive function in middle age, according to a study published in the September 2, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

A class of drugs used for many conditions, including allergies, colds, high blood pressure and depression, may be associated with an increased risk of developing mild thinking and memory problems, particularly in people who have genetic risk factors for Alzheimer’s disease or markers of this condition, according to a study published in the September 2, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

This is the 145th year for ANA's Annual Meeting, and is the first one ever to be held virtually. It will still feature the latest groundbreaking science and research in the field of academic neurology and neuroscience.

• share
• favorite_border

Researchers have long sought to explain precisely how the most common genetic mutation linked to both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia causes the death of nerve cells.

• share
• favorite_border

As you drift into unconsciousness before a surgery, general anesthetic drugs flowing through your blood are putting you to sleep by binding mainly to a protein in the brain called the ɣ-aminobutyric acid type A (GABAA) receptor. Now UT Southwestern scientists have shown exactly how anesthetics attach to the GABAA receptor and alter its three-dimensional structure, and how the brain can tell the difference between anesthetics and the psychoactive drugs known as benzodiazepines – which also bind to the GABAA receptor. The findings were published online today in the journal Nature.

• share
• favorite_border

• share
• favorite_border

In just the U.S. alone, more than 200 individuals are diagnosed with Multiple Sclerosis (MS) each week. However, when properly managed and controlled with medications and lifestyle adjustments, many of the common MS symptoms like visual and sensory loss, weakness and impared cognition can be mitigated.

• share
• favorite_border

Alzheimer’s disease is more common in rural Appalachian Ohio communities than in other rural areas in the state – raising concerns about access to early, specialized care in a region where many residents face struggles getting the medical care they need, a new study has found.

• share
• favorite_border

A study on serotonin, a mood-regulating molecule in the brain that regulates many brain synapses, is helping to unravel the puzzle surrounding its role in autism. The activity and regulation of the serotonin transporter (SERT), protein is critically dependent on a number of other proteins that tell the protein where to locate on nerve cells and how to act. Shifts in the transporter’s activity can significantly impact the ability of serotonin to act in the brain.

• share
• favorite_border

The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.

• share
• favorite_border

La telemedicina para el cuidado de la epilepsia es más popular que nunca. Tiene muchas ventajas, pero ¿Puede sostenerse en el futuro?

• share
• favorite_border

This rare but life-threatening condition is often due to an autoimmune response. Speedier diagnosis and more effective treatments are priorities.

• share
• favorite_border

The 8th Joint ACTRIMS-ECTRIMS meeting – the largest international conference focused on research in multiple sclerosis (MS), will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.

• share
• favorite_border

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.

• share
• favorite_border

Announcement of contents of the Neurosurgical Focus September issue

• share
• favorite_border

Warning about the threat of misinformation—before or after an event—significantly reduces the negative impact of misinformation on memory, according to research at Tufts University. The findings could have important implications for improving the accuracy of everyday memory and eyewitness testimony.

• share
• favorite_border

A new study of sleep, religious affiliation, and perceptions of heaven found that atheists and agnostics are significantly more likely to be better sleepers than Catholics and Baptists.

• share
• favorite_border

DALLAS – Aug. 31, 2020 – Three anticonvulsant drugs commonly used to stop prolonged, potentially deadly seizures each work equally well, according to a national study led by physicians at UT Southwestern. The results provide reassurance to patients who may have drug allergies and to physicians and hospitals that may not have supplies of all three.

• share
• favorite_border

Specific fungi in the gut associated with a higher risk of Alzheimer's disease and found in people with mild cognitive impairment (MCI) can be altered in a beneficial manner by eating a modified Mediterranean diet, researchers at Wake Forest School of Medicine have found.